Pulsed dye laser
DeviceThe scar will receive PDL 585 nm using a 7 mm spot size. First treatment will be within 1 year post injury.
NCT Number: NCT03986346
The purpose of this study is to explore the effects of pulsed dye laser on managing scar vascularity and thickness.
Looking for future studies?
Notify Me16 year–70 year
All sexes
Interventional
Not applicable
Southwest Hospital, Chongqing, China
The pulsed dye laser is increasingly used in clinical settings to manage scars and shows promising outcomes.The pulsed dye laser targets at micro-vascular structures in scar tissues. This study aims to explore the vascularity changes in scars with pulsed dye laser during the scar formation process.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The scar will receive PDL 585 nm using a 7 mm spot size. First treatment will be within 1 year post injury.
the scar will receive standardized care such as scar massage.
Time frame: 3 months
Dermoscopy captures the scar photo and measures degrees of scar erythema.
Time frame: 3 months
Ultrasound measures blood flow in scar tissues
Time frame: 3 months
Ultrasound measures scar thickness.
Time frame: 3 months
The POSAS measures scar vascularity, pigmentation, pigmentation, thickness, relief, pliability and surface area. Every parameter ranges from 1 to 10, and higher score indicates worse scar performance in that parameter. The total score of POSAS is calculated by summing all the parameters' scores.
The Hong Kong Polytechnic University
Other
The Vascularity Changes of Scars With Receiving Pulsed Dye Laser
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07718269
Cicatrix, Cicatrix, Hypertrophic
Alexandria, Egypt
View Trial DetailsNCT05434897
Cicatrix, Cicatrix, Hypertrophic
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT03692273
Burns, Cicatrix
Boston, Massachusetts, United States
View Trial DetailsNCT07263100
Cicatrix, Cicatrix, Hypertrophic
Sattahip, Changwat Chon Buri, Thailand
View Trial Details